Skip to main content
Erschienen in:

10.01.2022 | Chest

Preoperative percutaneous needle lung biopsy techniques and ipsilateral pleural recurrence in stage I lung cancer

verfasst von: Min Gwan Kim, Bo Ram Yang, Chang Min Park, Soon Ho Yoon

Erschienen in: European Radiology | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

A recent meta-analysis of individual patient data revealed that preoperative percutaneous transthoracic needle lung biopsy (PTNB) was associated with an increased risk of ipsilateral pleural recurrence in stage I lung cancer. This study aimed to examine whether particular PTNB techniques reduced the risk of pleural recurrence.

Methods

We retrospectively included 415 consecutive patients with stage I lung cancer who underwent preoperative PTNB and curative resection from 2009 through 2016. Detailed information was collected, including clinical, PTNB technique, radiologic, and pathologic characteristics of lung cancer. Cox regression analyses were performed to identify risk factors for pleural recurrence before and after propensity score matching.

Results

The overall follow-up period after PTNB was 62.1 ± 23.0 months, and ipsilateral pleural recurrence occurred in 40 patients. Before propensity score matching, age (p = 0.063), microscopic pleural invasion (p = 0.065), and pathologic tumor size (p = 0.016) tended to be associated with pleural recurrence in univariate analyses and subsequently were matched using a propensity score. After propensity score matching, multivariate analysis revealed that ipsilateral pleural recurrence was associated with a larger target size on computed tomography (hazard ratio [HR] = 1.498; 95% CI, 1.506–2.125; p = 0.023) and microscopic lymphatic invasion (HR = 3.526; 95% CI, 1.491–8.341; p = 0.004). However, no PTNB techniques such as needle gauge, biopsy, or pleural passage numbers were associated with a reduced risk of recurrence.

Conclusions

No particular PTNB techniques were associated with reduced pleural seeding after PTNB in stage I lung cancer. Regardless of the technique, PTNB needs to be cautiously applied when early lung cancer is suspected, followed by curative treatment.

Key Points

Age, microscopic pleural invasion, and pathologic tumor size tended to be associated with pleural recurrence in stage I lung cancer before propensity matching.
After propensity matching, pre-biopsy CT target size and microscopic lymphatic invasion were associated with pleural recurrence.
No particular PTNB techniques were associated with reduced pleural seeding in stage I lung cancer before and after propensity matching.
Literatur
1.
Zurück zum Zitat MacMahon H, Naidich DP, Goo JM et al (2017) Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology 284:228–243CrossRef MacMahon H, Naidich DP, Goo JM et al (2017) Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology 284:228–243CrossRef
2.
Zurück zum Zitat Gould MK, Donington J, Lynch WR et al (2013) Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e93S-e120SCrossRef Gould MK, Donington J, Lynch WR et al (2013) Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e93S-e120SCrossRef
3.
Zurück zum Zitat Callister ME, Baldwin DR, Akram AR et al (2015) British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 70(Suppl 2):ii1-ii54 Callister ME, Baldwin DR, Akram AR et al (2015) British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 70(Suppl 2):ii1-ii54
4.
Zurück zum Zitat Heerink WJ, de Bock GH, de Jonge GJ, Groen HJ, Vliegenthart R, Oudkerk M (2017) Complication rates of CT-guided transthoracic lung biopsy: meta-analysis. Eur Radiol 27:138–148CrossRef Heerink WJ, de Bock GH, de Jonge GJ, Groen HJ, Vliegenthart R, Oudkerk M (2017) Complication rates of CT-guided transthoracic lung biopsy: meta-analysis. Eur Radiol 27:138–148CrossRef
5.
Zurück zum Zitat Ahn SY, Yoon SH, Yang BR, Kim YT, Park CM, Goo JM (2019) Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer. Eur Radiol 29:270–278CrossRef Ahn SY, Yoon SH, Yang BR, Kim YT, Park CM, Goo JM (2019) Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer. Eur Radiol 29:270–278CrossRef
6.
Zurück zum Zitat Inoue M, Honda O, Tomiyama N et al (2011) Risk of pleural recurrence after computed tomographic-guided percutaneous needle biopsy in stage I lung cancer patients. Ann Thorac Surg 91:1066–1071CrossRef Inoue M, Honda O, Tomiyama N et al (2011) Risk of pleural recurrence after computed tomographic-guided percutaneous needle biopsy in stage I lung cancer patients. Ann Thorac Surg 91:1066–1071CrossRef
7.
Zurück zum Zitat Moon SM, Lee DG, Hwang NY et al (2017) Ipsilateral pleural recurrence after diagnostic transthoracic needle biopsy in pathological stage I lung cancer patients who underwent curative resection. Lung Cancer 111:69–74CrossRef Moon SM, Lee DG, Hwang NY et al (2017) Ipsilateral pleural recurrence after diagnostic transthoracic needle biopsy in pathological stage I lung cancer patients who underwent curative resection. Lung Cancer 111:69–74CrossRef
9.
Zurück zum Zitat Rami-Porta R, Bolejack V, Crowley J et al (2015) The IASLC Lung Cancer Staging Project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM Classification for Lung Cancer. J Thorac Oncol 10:990–1003 Rami-Porta R, Bolejack V, Crowley J et al (2015) The IASLC Lung Cancer Staging Project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM Classification for Lung Cancer. J Thorac Oncol 10:990–1003
10.
Zurück zum Zitat Schuchert MJ, Schumacher L, Kilic A et al (2011) Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer. Ann Thorac Surg 91:1059–1065; discussion 1065 Schuchert MJ, Schumacher L, Kilic A et al (2011) Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer. Ann Thorac Surg 91:1059–1065; discussion 1065
11.
Zurück zum Zitat Mirsadraee S, Oswal D, Alizadeh Y, Caulo A, van Beek E, Jr. (2012) The 7th lung cancer TNM classification and staging system: Review of the changes and implications. World J Radiol 4:128–134CrossRef Mirsadraee S, Oswal D, Alizadeh Y, Caulo A, van Beek E, Jr. (2012) The 7th lung cancer TNM classification and staging system: Review of the changes and implications. World J Radiol 4:128–134CrossRef
12.
Zurück zum Zitat Kim D-W (2012) Adjuvant chemotherapy in non-small cell lung cancer. Korean J Med 83:305–308CrossRef Kim D-W (2012) Adjuvant chemotherapy in non-small cell lung cancer. Korean J Med 83:305–308CrossRef
13.
Zurück zum Zitat Yoon SH, Lee SM, Park CH et al (2021) 2020 Clinical practice guideline for percutaneous transthoracic needle biopsy of pulmonary lesions: a consensus statement and recommendations of the Korean Society of Thoracic Radiology. Korean J Radiol 22:263–280CrossRef Yoon SH, Lee SM, Park CH et al (2021) 2020 Clinical practice guideline for percutaneous transthoracic needle biopsy of pulmonary lesions: a consensus statement and recommendations of the Korean Society of Thoracic Radiology. Korean J Radiol 22:263–280CrossRef
14.
Zurück zum Zitat Matsuguma H, Nakahara R, Kondo T, Kamiyama Y, Mori K, Yokoi K (2005) Risk of pleural recurrence after needle biopsy in patients with resected early stage lung cancer. Ann Thorac Surg 80:2026–2031CrossRef Matsuguma H, Nakahara R, Kondo T, Kamiyama Y, Mori K, Yokoi K (2005) Risk of pleural recurrence after needle biopsy in patients with resected early stage lung cancer. Ann Thorac Surg 80:2026–2031CrossRef
15.
Zurück zum Zitat Kudo Y, Saji H, Shimada Y et al (2012) Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer. Lung Cancer 78:153–160CrossRef Kudo Y, Saji H, Shimada Y et al (2012) Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer. Lung Cancer 78:153–160CrossRef
16.
Zurück zum Zitat Ayar D, Golla B, Lee JY, Nath H (1998) Needle-track metastasis after transthoracic needle biopsy. J Thorac Imaging 13:2–6CrossRef Ayar D, Golla B, Lee JY, Nath H (1998) Needle-track metastasis after transthoracic needle biopsy. J Thorac Imaging 13:2–6CrossRef
Metadaten
Titel
Preoperative percutaneous needle lung biopsy techniques and ipsilateral pleural recurrence in stage I lung cancer
verfasst von
Min Gwan Kim
Bo Ram Yang
Chang Min Park
Soon Ho Yoon
Publikationsdatum
10.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 4/2022
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-021-08359-x

Neu im Fachgebiet Radiologie

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Stören weiße Wände und viel Licht die Bildqualitätskontrolle?

Wenn es darum geht, die technische Qualität eines Mammogramms zu beurteilen, könnten graue Wandfarbe und reduzierte Beleuchtung im Bildgebungsraum von Vorteil sein. Darauf deuten zumindest Ergebnisse einer kleinen Studie hin. 

PMBCL mit CMR: Radiatio kann ohne Risiko weggelassen werden

Patienten mit primär mediastinalem B-Zell-Lymphom (PMBCL), die nach der Induktionstherapie eine komplette metabolische Remission (CMR) erreichen und keine konsolidierende Bestrahlung erhalten, müssen offenbar keine Überlebensnachteile fürchten.

Hypoxisch-ischämische Enzephalopathie: Indikatoren für eine ungünstige Prognose

Eine US-amerikanische Studie widmete sich der Identifizierung prognostischer Parameter bei Neugeborenen mit mittelschwerer oder schwerer hypoxisch-ischämischer Enzephalopathie (HIE), die mittels induzierter Hypoxie behandelt wurden. Besonders im 24-Stunden-EEG und der MRT konnten relevante Hinweise gefunden werden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.